Abstract
The risk of a subsequent relapse tumor resectable breast cancer - the main factor to indicate the use of adjuvant chemotherapy to a patient is extrapolated from the characteristics of the tumor and not in the detection of residual tumor cells in the patient. This is due to the current absence of complementary methods routinely sensitive enough to detect a very small amount of residual bre…